EUR 2.75
(-1.4%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 110.38 Million EUR | 39.23% |
2022 | 92.43 Million EUR | -5.61% |
2021 | 89.65 Million EUR | 29.73% |
2020 | 59.39 Million EUR | 13.97% |
2019 | 51.27 Million EUR | 32.72% |
2018 | 21.35 Million EUR | 125.46% |
2017 | 6.89 Million EUR | -21.13% |
2016 | 15.07 Million EUR | 143.01% |
2015 | 10.16 Million EUR | 1170.32% |
2014 | -950 Thousand EUR | -105.91% |
2013 | 16.07 Million EUR | 8.22% |
2012 | 14.85 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 21.78 Million EUR | 0.0% |
2024 Q1 | 21.78 Million EUR | -15.84% |
2023 Q2 | 19.9 Million EUR | 0.0% |
2023 Q3 | 25.88 Million EUR | 30.05% |
2023 Q4 | 25.88 Million EUR | 0.0% |
2023 FY | - EUR | 39.23% |
2023 Q1 | 19.9 Million EUR | -8.96% |
2022 Q4 | 21.86 Million EUR | 0.0% |
2022 Q1 | 18.97 Million EUR | 7.26% |
2022 Q3 | 21.86 Million EUR | 15.19% |
2022 FY | - EUR | -5.61% |
2022 Q2 | 18.97 Million EUR | 0.0% |
2021 Q2 | 16.42 Million EUR | 0.0% |
2021 Q4 | 17.69 Million EUR | 0.0% |
2021 FY | - EUR | 29.73% |
2021 Q3 | 17.69 Million EUR | 7.75% |
2021 Q1 | 16.42 Million EUR | 14.34% |
2020 Q2 | 12.59 Million EUR | 0.0% |
2020 FY | - EUR | 13.97% |
2020 Q4 | 14.36 Million EUR | 0.0% |
2020 Q3 | 14.36 Million EUR | 14.05% |
2020 Q1 | 12.59 Million EUR | -1.31% |
2019 Q1 | 10.57 Million EUR | 3.5% |
2019 FY | - EUR | 32.72% |
2019 Q4 | 12.76 Million EUR | 0.0% |
2019 Q3 | 12.76 Million EUR | 20.69% |
2019 Q2 | 10.57 Million EUR | 0.0% |
2018 Q1 | 4.36 Million EUR | -49.49% |
2018 Q4 | 10.21 Million EUR | 0.0% |
2018 FY | - EUR | 125.46% |
2018 Q3 | 10.21 Million EUR | 134.25% |
2018 Q2 | 4.36 Million EUR | 0.0% |
2017 Q1 | 1.81 Million EUR | 0.0% |
2017 Q2 | 1.81 Million EUR | 0.0% |
2017 Q4 | 8.63 Million EUR | 0.0% |
2017 FY | - EUR | -21.13% |
2016 FY | - EUR | 143.01% |
2016 Q2 | 4 Million EUR | 0.0% |
2016 Q1 | 4 Million EUR | 0.0% |
2016 Q4 | 1.81 Million EUR | 0.0% |
2015 Q4 | 4 Million EUR | 0.0% |
2015 FY | - EUR | 1170.32% |
2014 FY | - EUR | -105.91% |
2013 FY | - EUR | 8.22% |
2012 FY | - EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Bastide Le Confort Médical SA | 110.32 Million EUR | -0.057% |